Brownstein BH, et al. (2006): Commonality and differences in leukocyte gene expression patterns among three models of inflammation and injury. Physiol Genomics 24(3):298–309.
Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D (2005): Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12(1):60–67.
Mestas J, Hughes CC (2004): Of mice and not men: Differences between mouse and human immunology. J Immunol 172(5): 2731–2738.
Cabrera O, et al. (2006): The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 103(7):2334–2339.
Schneider DS, Ayres JS (2008): Two ways to survive infection: What resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol 8(11):889–895.
Schaedler RW, Dubos RJ (1961): The susceptibility of mice to bacterial endotoxins. J Exp Med 113:559–570.
-> Neu: Stebbings, R., Findlay, L., Edwards, C., Eastwood, D., Bird, C., North, D., Mistry, Y., Dilger, P., Liefooghe, E., Cludts, I., Fox, B., Tarrant, G., Robinson, J., Meager, T., Dolman, C. & Thorpe, S. J. (2007): “Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics. J Immunol 179: 3325-3331.
Warren HS, et al. (2010): Resilience to bacterial infection: Difference between species could be due to proteins in serum.
J Infect Dis 201(2):223–232.
Sauter C, Wolfensberger C (1980): Interferon in human serum after injection of endotoxin. Lancet 2(8199):852–853.